
News|Articles|March 8, 2015
Thyroid Hormone Receptor and Runx2 Expression in Thyroid Cancer Cells
Author(s)Frances Carr, PhD
Frances Carr, PhD, professor, Department of Pharmacology, The University of Vermont, discusses the relationship between the thyroid hormone receptor and Runx2 expression in thyroid cancer cells.
Advertisement
References
Frances Carr, PhD, professor, Department of Pharmacology, The University of Vermont, discusses the relationship between the thyroid hormone receptor and Runx2 expression in thyroid cancer cells.
- The thyroid hormone receptor is a possible tumor suppressor.
- Studies have shown that Runx2 may be a tumor promoter in papillary thyroid cancer.
- An inverse relationship was seen between thyroid hormone receptor expression and Runx2.
- This relationship is being explored and could have therapeutic implications in the future.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5









































